View full programming schedule
Future of Keystone XL Agrium Proxy Battle Federal Budget 2013 Your Money Month PDAC 2013 BNN Book Club Passion Capitalist Financial Glossary Bell Let's Talk Talking Tax C-Suite Survey SNC-Lavalin Annual Meeting

Are you looking for a stock?

Try one of these

News Tagged By: Pharmaceuticals

Valeant adjusted profit up; raises profit forecast

Valeant Pharmaceuticals International Inc., Canada's biggest publicly traded drugmaker, reported a 12-percent rise in adjusted quarterly profit due to higher product sales and raised its full-year...

Posted on 5-02-2013 at 8:57 AM
Tags: Valeant Pharmaceuticals, Pharmaceuticals

Jean Coutu misses profit expectations, boosts dividend

Canadian pharmacy chain Jean Coutu Group Inc.'s fourth-quarter profit missed analysts' expectations as tighter price controls for generic drugs hit revenue.

Posted on 5-01-2013 at 8:13 AM
Tags: Jean Coutu, Pharmaceuticals

Merck's diabetes drug lags, cuts 2013 forecast

Merck & Co Inc. reported disappointing first-quarter sales on a surprising downturn for its Januvia diabetes medicine, the company's biggest product and usual earnings driver, and the...

Posted on 5-01-2013 at 11:02 AM
Tags: Merck & Co, Pharmaceuticals

Merger of Valeant, Actavis on hold: Report

A proposed merger of Valeant Pharmaceuticals International Inc. and Actavis Inc. was put on hold after the two drugmakers failed to agree on terms of a deal that would have created a healthcare...

Posted on 4-29-2013 at 8:16 AM
Tags: Valeant Pharmaceuticals, Pharmaceuticals

Valeant Pharma looks set to nab Obagi Medical

Germany's Merz Pharma Group withdrew its offer for U.S. cosmetic products maker Obagi Medical Products Inc., after rival bidder Canada's Valeant Pharmaceuticals International Inc. raised its offer...

Posted on 4-08-2013 at 12:30 PM
Tags: Valeant Pharmaceuticals, Pharmaceuticals

Valeant sweetens bid for Obagi Medical

Valeant Pharmaceuticals International Inc. raised its offer for cosmetics products maker Obagi Medical Products Inc. to $24 per share US, a day after its initial bid was topped by German drugmaker...

Posted on 4-03-2013 at 9:48 AM
Tags: Pharmaceuticals, Valeant Pharmaceuticals

Novartis loses landmark India patent case on Glivec

India's top court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a...

Posted on 4-01-2013 at 9:42 AM
Tags: Novartis, India, Pharmaceuticals, Patents

Bad Pharma’s bitter pill to swallow

INSIDE THE CHASE: You know you’re going to ruffle a few feathers when you give the title Bad Pharma to your latest book alleging how the pharmaceutical industry misleads both doctors and consumers,...

Posted on 2-22-2013 at 5:33 PM
Tags: Pharmaceuticals

Valeant aims to double or quadruple revenue

Valeant Pharmaceuticals International Inc., already Canada's biggest listed drugmaker, could double or quadruple revenue "in the foreseeable future," the company's chief executive said on Friday.

Posted on 1-04-2013 at 9:38 AM
Tags: Valeant Pharmaceuticals, Pharmaceuticals

Gilead bags blood disorder drug with YM BioSciences buy

Gilead Sciences Inc will buy Canada's YM BioSciences Inc for about $465 million US in cash to gain access to its experimental blood and immune cell disorder drug.

Posted on 12-12-2012 at 10:24 AM
Tags: Gilead Sciences, Pharmaceuticals
Latest News
Popular News

Today's Guests